Overview

A Study to Evaluate the Pharmacokinetics and Safety of Brivaracetam in Healthy Chinese Subjects

Status:
Completed
Trial end date:
2021-06-08
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the pharmacokinetics, safety, and tolerability of brivaracetam after a single dose and multiple doses in healthy adult Chinese Study Participants.
Phase:
Phase 1
Details
Lead Sponsor:
UCB Biopharma SRL
Treatments:
Brivaracetam